Zytix 250 MG (Abiraterone Acetate)

Basic Product Information of Zytix (Abiraterone Acetate) 250mg

How Zytix (Abiraterone Acetate) Works

Zytix contains Abiraterone Acetate, an oral prodrug that is converted to abiraterone, a selective and irreversible inhibitor of the CYP17 enzyme (17α-hydroxylase/C17,20-lyase). CYP17 is essential for androgen (testosterone) biosynthesis, and prostate cancer cells rely on androgen signalling to grow and survive.

By blocking CYP17, Zytix suppresses androgen production at all three key sources: the testes, the adrenal glands, and the prostate tumour tissue itself. This goes beyond conventional androgen deprivation therapy (medical or surgical castration), which addresses only testicular androgen production, giving a more complete blockade of the hormonal signals driving prostate cancer.

Because CYP17 inhibition also raises upstream steroid precursors, leading to excess mineralocorticoid activity, Zytix is always given together with a low-dose corticosteroid (prednisone or prednisolone) to counteract this effect. Zytix is a once-daily oral tablet, taken on an empty stomach, alongside ongoing medical or surgical castration in patients who have not had surgical castration.

Indications for Zytix (Abiraterone Acetate)

Zytix (Abiraterone Acetate) is indicated for the following conditions, always in combination with a corticosteroid:

Benefits of Zytix (Abiraterone Acetate) 250mg

How to Take Zytix (Abiraterone Acetate)

Monitoring and Dosage Adjustments

Regular monitoring is essential during Zytix treatment. Your healthcare provider will monitor blood pressure, serum potassium, and fluid retention monthly, or every 2 weeks for the first 3 months in patients at higher risk of heart failure. Liver function tests should be checked before starting treatment, every 2 weeks for the first 3 months, and monthly thereafter. Your provider will also watch for signs of adrenocortical insufficiency, particularly if the corticosteroid dose is reduced or stopped, or during periods of unusual stress, illness, or surgery, when a temporarily increased corticosteroid dose may be needed. Report any unusual weakness, dizziness, swelling, or muscle weakness to your doctor immediately.

Drug Interactions and Important Information

Zytix is metabolised through CYP3A4; avoid strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin, and St. John’s Wort, as these can reduce Abiraterone efficacy. Abiraterone also inhibits CYP2D6, so caution is required with other CYP2D6-metabolised medications that have a narrow therapeutic index.

Avoid co-administration with spironolactone, as its androgenic/anti-androgenic activity can interfere with Abiraterone’s effect. Zytix must be taken on an empty stomach, as food substantially increases absorption. Always inform your physician of all medications, supplements, and herbal products you are currently taking before starting Zytix.

Side Effects and Precautions

Who Should Use Zytix (Abiraterone Acetate)?

Zytix is suitable for adult men diagnosed with metastatic castration-resistant prostate cancer or newly diagnosed, high-risk metastatic castration-sensitive prostate cancer, used together with a corticosteroid and, where applicable, ongoing medical castration. It is prescribed by urologists, oncologists, and specialist physicians experienced in managing prostate cancer. Baseline blood pressure, liver function, and serum potassium should be assessed before starting treatment.

Manufacturer

Zytix (Abiraterone Acetate) is manufactured in Bangladesh under strict WHO-GMP, cGMP, and ISO-certified standards, offering an affordable and bioequivalent alternative to Zytiga by Janssen at a fraction of the cost. [Please confirm the exact manufacturer name so it can be added here and in the specs table above.]

Global Supplier: Mediaid Pharmacy with Worldwide Shipping

Mediaid Pharmacy is a trusted global supplier of specialty oncology medications. We ensure Zytix (Abiraterone Acetate) is accessible to patients and healthcare providers worldwide through reliable worldwide shipping. Whether you are located in South Asia, the Middle East, Africa, Europe, or beyond, Mediaid Pharmacy provides fast and reliable delivery with full order support. Contact us directly via WhatsApp, phone, or WeChat for pricing, availability, and delivery enquiries.

Why Choose Zytix (Abiraterone Acetate) from Mediaid Pharmacy?

Zytix represents an important hormonal therapy option for men with advanced prostate cancer. As the generic equivalent of Zytiga by Janssen, it delivers the same active ingredient, Abiraterone Acetate, with the same proven CYP17 inhibition mechanism at a dramatically more affordable price. Manufactured under WHO-GMP and cGMP standards and distributed globally by Mediaid Pharmacy, Zytix gives patients worldwide access to high-quality targeted prostate cancer therapy without the financial burden of brand-name alternatives. For patients and physicians seeking a proven, affordable, and accessible Abiraterone Acetate option with worldwide delivery, Zytix from Mediaid Pharmacy is the trusted choice.

Frequently Asked Questions About Zytix (Abiraterone Acetate)